Related Experiment Video
Updated: May 15, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
CROI 2026: Tuberculosis and Other Infectious Complications in People With HIV
Andrew D Kerkhoff1, Jason Zucker2, Diane V Havlir1
1University of California San Francisco, San Francisco, CA, USA.
Abstract:
The 2026 Conference on Retroviruses and Opportunistic Infections (CROI) featured numerous studies on tuberculosis and other opportunistic infections in people with HIV. High mortality rate among people with HIV hospitalized with disseminated tuberculosis (TB) and among those treated for drug-resistant TB represents a major clinical challenge. Intensified TB treatment in one trial and adjunctive prednisone in another failed to reduce mortality in hospitalized people with HIV with disseminated TB. In addition, a novel higher-dose linezolid dosing strategy did not improve culture conversion in drug-resistant TB. Recommended options for TB prevention are increasing, and include 1-month daily (1HP) and 3-month weekly (3HP) isoniazid-rifapentine regimens. Two head-to-head trials comparing 1HP and 3HP found comparable efficacy, although 1HP was associated with lower treatment completion rate and greater treatment intolerance. These and other key findings from TB, mpox, and other opportunistic infection-related studies are summarized herein.
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Sexually Transmitted Infections
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
